Evidence map›Paper›PMID 29697762›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2018

Longitudinal Trajectories of Brain Volume and Cortical Thickness in Treated and Untreated Primary Human Immunodeficiency Virus Infection.

Ryan Sanford, Beau M Ances, Dieter J Meyerhoff, Richard W Price, Dietmar Fuchs, Henrik Zetterberg, Serena Spudich, D Louis Collins

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 3 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 3 syntheses or guidelines pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 5 countries.

Ryan SanfordDepartment of Biological and Biomedical Engineering, Montreal Neurological Institute, Quebec, Canada.
Beau M AncesDepartment of Neurology, University of Washington, St Louis, Missouri.
Dieter J MeyerhoffDepartment of Radiology and Biomedical Imaging, Austria.
Richard W PriceDepartment of Neurology, University of California, San Francisco School of Medicine, Austria.
Dietmar FuchsDivision of Biological Chemistry, Innsbruck Medical University, Austria.
Henrik ZetterbergDepartment of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg, Sweden.
Serena SpudichDepartment of Neurology, Yale School of Medicine, New Haven, Connecticut.
D Louis CollinsDepartment of Biological and Biomedical Engineering, Montreal Neurological Institute, Quebec, Canada.
Montreal Neurological Institute and Hospital · CAEuropean Institute for Biomedical Imaging Research · ATInnsbruck Medical University · ATSahlgrenska University Hospital · SEUniversity of California, San Francisco · USUniversity of Washington · USYale University · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
The Neuropathobiology of Primary HIV-1 InfectionR01MH081772 · NIMH · YALE UNIVERSITY · PI SPUDICH, SERENA S · 2008 to 2013
$2.7M
Central Nervous System Events in Primary HIV InfectionK23MH074466 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SPUDICH, SERENA S · 2005 to 2009
$835k
Structural Neuroimaging Markers in Primary HIV InfectionR21MH099979 · NIMH · YALE UNIVERSITY · PI ANCES, BEAU M, SPUDICH, SERENA S · 2013 to 2014
$350k
NIAID NIH HHS P30 AI027763NIMH NIH HHS K23 MH074466NIMH NIH HHS R01 MH081772NIMH NIH HHS R21 MH099979
6 · The paper itself

Abstract

Background: Human immunodeficiency virus (HIV) penetrates the brain in early infection. We used neuroimaging to longitudinally examine the impact of HIV and combination antiretroviral therapy (cART) on the brain in treated and untreated HIV-infected participants, starting in primary HIV infection (PHI). Methods: Sixty-five participants, enrolled during PHI, underwent longitudinal magnetic resonance imaging, 30 of whom commenced cART during follow-up. Cross-sectional data from 16 patients with chronic HIV infection (CHI) and 19 HIV-uninfected participants were included for comparison. Brain volume and cortical thickness were estimated using tensor-based morphometry and cortical modeling, respectively. Mixed-effects models longitudinally mapped structural brain changes before and after cART. The relationship between brain morphometry estimates and blood and cerebrospinal fluid (CSF) biomarkers were also tested. Region-of-interest analyses were performed to compare brain morphometry estimates between the groups. Results: Prior to cART, longer duration of untreated infection in PHI correlated with volume loss in the thalamus, caudate, and cerebellum, and with cortical thinning in the frontal and temporal lobes and cingulate cortex. After cART, no further volume loss was observed. However, small increases of cortical thickness in the frontal and temporal lobe correlated with longer cART duration. No correlations were observed with blood or CSF measures. The PHI group did not have different brain morphometric measures compared to the HIV-uninfected group, but had larger volumes in the thalamus, caudate, putamen, and cortical gray matter compared with CHI participants. Conclusions: Subcortical atrophy and cortical thinning occur during untreated infection but may be arrested by cART. These findings emphasize the importance of early cART.

Indexed as

AdultAnti-Retroviral AgentsBiomarkersBrainCerebral CortexCross-Sectional StudiesDrug Therapy, CombinationFemaleHIV InfectionsHumansLongitudinal StudiesMagnetic Resonance ImagingMaleMiddle AgedNeuroimagingAnti-Retroviral AgentsBiomarkers

Identifiers

PMID29697762
PMCPMC6233681
OpenAlexW2799834541

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.